The ASRM Coding Blog offers expert guidance on fertility and reproductive medicine billing, CPT coding updates, insurance tips, and coding FAQs for providers.
Practice documents and guidelines developed by the ASRM Coding Committee for reproductive medicine and coding professionals to aid with reimbursement and correct coding of procedures.
Preimplantation genetic testing for adult-onset monogenic diseases is ethically allowed when fully penetrant or conferring disease predisposition.
The use of hormonal contraception can be considered to aid in the timing of assisted reproductive technology cycles, reduce the risk of ovarian cysts at in vitro fertilization cycle initiation,
Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public (such as live birth) nor on the harms, including
The use of preimplantation genetic testing for aneuploidy (PGT-A) in the United States has been increasing steadily.
Methodological limitations in studying the association between the use of fertility drugs and cancer include the inherent increased risk of cancer in women who never conceive, the increased risk
ASRM’s scorecard guides voters on IVF and reproductive health positions of federal officials, with color indicators showing support or opposition to key bills
ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices.
Explore ASRM's comprehensive data on IVF births across U.S. states, highlighting regional trends and the impact of assisted reproductive technologies nationwide.
Displaying 551 to 560 of 1683 records
